Press release
Global Nuclear Medicine Market to grow at a CAGR of 9.67% by 2030, Evaluates DelveInsight | Lantheus., Cardinal Health., GE Healthcare, Curium Pharma, Nihon Medi-Physics Co., Ltd., Novartis (Advanced Accelerator Applications), Cambridge Isotope Laboratori
According to DelveInsight's analysis, The nuclear medicine/radiopharmaceuticals market is experiencing significant growth driven by the rising incidence of cancer, cardiovascular conditions, and other chronic illnesses linked to sedentary lifestyles. Moreover, the expanding elderly population-more vulnerable to such diseases-along with the growing global demand for image-guided diagnostics and procedures, and a strong pipeline of upcoming products, is expected to boost market demand. Supportive government initiatives aimed at enhancing access to nuclear medicine, along with increasing research collaborations and strategic partnerships, are also contributing to the market's expansion.DelveInsight's "Nuclear Medicine Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Nuclear Medicine companies actively working in the market.
To know more about why North America is leading the market growth in the Nuclear Medicine market, get a snapshot of the report Nuclear Medicine Market Trends
https://www.delveinsight.com/sample-request/nuclear-medicine-radiopharmaceuticals-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Nuclear Medicine Overview
Nuclear medicine is a specialized area of medical imaging that uses small amounts of radioactive materials (radiotracers) to diagnose and treat diseases. These radiotracers are introduced into the body-often through injection, swallowing, or inhalation-and then detected by special cameras to provide detailed images of internal organs and tissues. It is widely used in detecting cancers, heart diseases, and neurological disorders, as well as for targeted therapies like radioactive iodine treatment for thyroid cancer.
DelveInsight Analysis: The global nuclear medicine (radiopharmaceuticals) market was valued at USD 7,203.62 million in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 9.67% from 2024 to 2030, reaching approximately USD 12,495 million by the end of the forecast period.
Nuclear Medicine Market Insights
Geographically, North America is projected to lead the global nuclear medicine/radiopharmaceuticals market in 2021 and maintain its dominance throughout the forecast period (2024-2030). This growth is primarily attributed to the rising prevalence of cancer, cardiovascular diseases, and other chronic conditions, largely driven by lifestyle changes and high consumption of processed foods. Additionally, the presence of major industry players, an increasing elderly population susceptible to chronic illnesses, and a supportive reimbursement landscape for radiopharmaceuticals in the U.S. are key factors fueling market expansion in the region.
To read more about the latest highlights related to Nuclear Medicine, get a snapshot of the key highlights entailed in the Nuclear Medicine
https://www.delveinsight.com/report-store/nuclear-medicine-radiopharmaceuticals-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Nuclear Medicine Market Report
• In March 2022, Bracco Imaging introduced Blue Earth Therapeutics to drive progress in therapeutic radiopharmaceutical technology. The company is developing a pipeline of precision-targeted radiopharmaceutical therapies, initially aimed at treating prostate cancer, with future plans to broaden its focus to other oncology indications.
• In February 2022, Applied Molecular Therapies introduced 177Lu PSMATherapy, a targeted radiopharmaceutical treatment specifically designed for prostate cancer therapy.
• In February 2022, Cerveau Technologies, Inc. and Nihon Medi-Physics have entered into a manufacturing service agreement, under which Cerveau has authorized NMP to produce [18F] MK-6240, an advanced investigational PET imaging agent.
• Thus, owing to such developments in the market, rapid growth will be observed in the Nuclear Medicine market during the forecast period
Key Players in the Nuclear Medicine Market
Some of the key market players operating in the Nuclear Medicine market include- Lantheus., Cardinal Health., GE Healthcare, Curium Pharma, Nihon Medi-Physics Co., Ltd., Novartis (Advanced Accelerator Applications), Cambridge Isotope Laboratories, Inc, Sotera Health LLC, Bracco Imaging SpA, Jubilant Pharma Limited, Necsa, IBA Radiopharma Solutions, Bayer AG, Norgine, Eczacıbaşı-Monrol, NorthStar Medical Radioisotopes, LLC., Eckert & Ziegler., Telix Pharmaceuticals Limited, ITM Isotope Technologies Munich SE, Mallinckrodt PLC, and others.
Which MedTech key players in the Nuclear Medicine market are set to emerge as the trendsetter explore @ Key Nuclear Medicine Companies
https://www.delveinsight.com/sample-request/nuclear-medicine-radiopharmaceuticals-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Nuclear Medicine Market Landscape
Growing technological innovations in disease diagnosis and treatment, along with the rising approvals of new nuclear medicine devices that meet patient treatment needs, are expected to propel the market in the coming years. For example, in September 2021, GE Healthcare introduced an advanced nuclear medicine scanner featuring an automated workflow, providing detailed views of cardiac anatomy and pathology to assist physicians in making accurate treatment decisions.
The COVID-19 pandemic had an adverse impact on the nuclear medicine/radiopharmaceuticals market due to the suspension of non-urgent hospital admissions and outpatient visits, which led to a decline in routine diagnostic and clinical procedures. However, the development and rollout of COVID-19 vaccines supported economic recovery and eased lockdown restrictions, gradually restoring healthcare operations. As regular medical services, including outpatient diagnostics and treatments, resumed, the demand for nuclear medicine and radiopharmaceutical products began to recover, helping the market regain momentum.
Scope of the Nuclear Medicine Market Report
• Coverage: Global
• Study Period: 2021-2030
• Nuclear Medicine Market Segmentation By Type: (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
• Nuclear Medicine Market Segmentation By Application Type: Pain Management, Bowel & Bladder Control, Parkinson's Disease, Epilepsy, and Others
• Nuclear Medicine Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
• Nuclear Medicine Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Nuclear Medicine Companies: Lantheus., Cardinal Health., GE Healthcare, Curium Pharma, Nihon Medi-Physics Co., Ltd., Novartis (Advanced Accelerator Applications), Cambridge Isotope Laboratories, Inc, Sotera Health LLC, Bracco Imaging SpA, Jubilant Pharma Limited, Necsa, IBA Radiopharma Solutions, Bayer AG, Norgine, Eczacıbaşı-Monrol, NorthStar Medical Radioisotopes, LLC., Eckert & Ziegler., Telix Pharmaceuticals Limited, ITM Isotope Technologies Munich SE, Mallinckrodt PLC, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Nuclear Medicine market will grow by 2030? Click to get a snapshot of the Nuclear Medicine Market Analysis
https://www.delveinsight.com/sample-request/nuclear-medicine-radiopharmaceuticals-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Nuclear Medicine Market Report Introduction
2 Nuclear Medicine Market Executive summary
3 Regulatory and Patent Analysis
4 Nuclear Medicine Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Nuclear Medicine Market
7 Nuclear Medicine Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11 Nuclear Medicine Market Drivers
12 Nuclear Medicine Market Barriers
13 About DelveInsight
Latest Reports by DelveInsight
• Drug-eluting Stents Market Market: https://www.delveinsight.com/report-store/drug-eluting-stents-market
• Sinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Cervical Dysplasia Market: https://www.delveinsight.com/report-store/cervical-dysplasia-market-insights
• Hypogonadism Market: https://www.delveinsight.com/report-store/hypogonadism-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Non-hodgkin's Lymphoma Market: https://www.delveinsight.com/report-store/non-hodgkins-lymphoma-market
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
Connect With Us at:
LinkedIn | Facebook | Twitter
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Nuclear Medicine Market to grow at a CAGR of 9.67% by 2030, Evaluates DelveInsight | Lantheus., Cardinal Health., GE Healthcare, Curium Pharma, Nihon Medi-Physics Co., Ltd., Novartis (Advanced Accelerator Applications), Cambridge Isotope Laboratori here
News-ID: 4070921 • Views: …
More Releases from DelveInsight Business Research
Global Intranasal Drug Delivery Market to reach USD 104,248.63 million by 2032 a …
According to DelveInsight's analysis, The Intranasal Drug Delivery market expansion is largely fueled by the growing burden of chronic conditions such as neurological, respiratory, severe allergic, and eye-related disorders. The rising preference for fast-acting, non-invasive drug delivery solutions is also boosting the market, as intranasal administration provides quick absorption and user-friendly dosing, improving both adherence and treatment outcomes. Additionally, increased research efforts and a wave of new product introductions from…
Global Clinical Trial Support Services Market to reach USD 43,160.56 million by …
According to DelveInsight's analysis, The clinical trial support services market is expanding swiftly, largely driven by the increasing incidence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases. This rise has resulted in a higher volume of clinical trials, greater R&D spending, and stronger investment in new drug development. Moreover, the growing collaboration among pharmaceutical, biotechnology, and medical device companies is boosting the need for specialized services, including regulatory…
Global Respiratory Inhalers Market to reach USD 51,132.25 million by 2032 at a C …
According to DelveInsight's analysis, The demand for respiratory inhalers is rising sharply, driven by a combination of factors. Chief among these is the increasing prevalence of respiratory disorders, including asthma, COPD, bronchitis, and bronchospasm, which continue to impact a growing global population and create a need for fast and effective treatments. Simultaneously, patient awareness regarding early diagnosis and consistent management of asthma and COPD is improving, further supporting market growth.…
Global Dysmenorrhea Treatment Market to reach USD 7,909.14 million by 2032 at a …
According to DelveInsight's analysis, The widespread occurrence of dysmenorrhea (menstrual pain), along with rising awareness and better diagnostic practices, is driving strong growth in the dysmenorrhea treatment market. As more women seek professional care for menstrual pain, the need for effective therapies from OTC painkillers to hormonal treatments continues to increase. Awareness initiatives and educational programs are also reducing stigma and promoting earlier treatment-seeking behavior. Meanwhile, leading companies are advancing…
More Releases for Nuclear
Nuclear Energy Market is Going to Boom : GE Hitachi Nuclear Energy, China Nation …
HTF MI introduces new research on Nuclear Energy covering the micro level of analysis by competitors and key business segments (2023-2029). The Nuclear Energy explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing.
Some of the major key players profiled…
Nuclear Technology Market Is Booming Worldwide | Areva, Foro Nuclear, Emirates N …
Advance Market Analytics published a new research publication on "Nuclear Technology Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Nuclear Technology market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of…
Nuclear Reactor Market - Crucial business trends 2025 | FirstEnergy Nuclear Gene …
Global Nuclear Reactor Market: Snapshot
The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’…
Nuclear Reactor Market - Promising growth opportunities 2025 | FirstEnergy Nucle …
Global Nuclear Reactor Market: Snapshot
The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’…
Nuclear Energy Industry Analysis of Nuclear Fuels Market 2017-2021
Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate electricity.
. .
– Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1069449
' '
Global nuclear fuels market to grow…
UAE Nuclear Power Sector UAE Nuclear Power Sales Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. UAE Power Sector Scenario
1.1 Existing Power Generation Outlook
1.2 Current & Projected Power Demand
2. Why UAE Energy Policy beyond Oil & Gas?
3. UAE Nuclear Power Sector Overview
3.1 UAE Entering into Nuclear Power Sector
3.2 Nuclear Policy Overview
4. UAE Nuclear Power Sector Dynamics
4.1 Favorable Parameters
4.2 Nuclear Power Sector…
